Dependence Of Heart Failure On Time Of Day.
Patients hospitalized for insensitivity discontinuance appear to have better odds of survival if they're admitted on Mondays or in the morning, a unfamiliar study finds in May 2013. Death rates and length of stay are highest surrounded by heart failure patients admitted in January, on Fridays and overnight, according to the researchers, who are scheduled to hand-out their findings Saturday in Portugal at the annual meeting of the Heart Failure Association of the European Society of Cardiology. "The reality that patients admitted right before the weekend and in the middle of the night do worse and are in the sanatorium longer suggests that staffing levels may contribute to the findings," Dr David Kao, of the University of Colorado School of Medicine, said in a newsflash release from the cardiology society.
And "Doctors and hospitals want to be more vigilant during these higher-risk times and ensure that adequate resources are in place to get along with demand. Patients should be aware that their disease is not the same over the course of the year, and they may be at higher risk during the winter. People often escape coming into the hospital during the holidays because of family pressures and a personal desire to stay at home, but they may be putting themselves in danger".
The on involved 14 years of data on more than 900000 patients with congestive affection failure, a condition in which the heart doesn't properly pump blood to the rest of the body. All of the patients were admitted to hospitals in New York between 1994 and 2007.
The researchers analyzed the potency the hour, epoch and month of the patients' admissions had on death rates and the length of tempo they spent in the hospital. Patients admitted between 6 AM and noon fared better than evening admissions, the ponder found.
Showing posts with label heart. Show all posts
Showing posts with label heart. Show all posts
Tuesday, 4 February 2020
Thursday, 16 January 2020
Treatment Of Heart Attack With The Help Of Stem Cells From Belly Fat
Treatment Of Heart Attack With The Help Of Stem Cells From Belly Fat.
Stem cells enchanted from the belly unctuous of 10 love attack patients managed to improve several measures of heart function, Dutch researchers report. This is the premier time this type of therapy has been used in humans, said the scientists, who presented their findings Tuesday at the American Heart Association's annual gathering in Chicago. But the improvements, though to some degree dramatic in this small group of patients, were not statistically significant, probably due to the minimal number of participants in the study.
And another expert urged caution when interpreting the results. "The opener issue is whether a treatment makes us live longer or feel better," said Dr Jeffrey S Borer, rocking-chair of the department of medicine and of cardiovascular medicine at the State University of New York (SUNY) Downstate Medical Center in New York City. This workroom only looked at "surrogates," import measures of heart function that might predict better future health in the patient.
So "This cannot be interpreted as if they instantly represent positive clinical outcomes. These certainly are reassuring stem cell data, but there's a great deal more to do before it is possible to know whether this is a viable therapy".
Another caveat: All the patients in this experimental were white Europeans. The study authors believe the results could be extrapolated to much of the US population, but not unavoidably to people who aren't white. Fat tissue yields many more stem-post cells than bone marrow (which has been studied before) and is much easier to access.
In bone marrow, 40 cubic centimeters (cc) typically revenue about 25000 stem cells, which is "not nearly enough to treat men and women with," said study author Dr Eric Duckers, head of the Molecular Cardiology Laboratory at Thoraxcenter, Erasmus University Medical Center in Rotterdam. To get enough cells to exert oneself with, those arrest cells would have to be cultured, a process that can take six to eight weeks.
Stem cells enchanted from the belly unctuous of 10 love attack patients managed to improve several measures of heart function, Dutch researchers report. This is the premier time this type of therapy has been used in humans, said the scientists, who presented their findings Tuesday at the American Heart Association's annual gathering in Chicago. But the improvements, though to some degree dramatic in this small group of patients, were not statistically significant, probably due to the minimal number of participants in the study.
And another expert urged caution when interpreting the results. "The opener issue is whether a treatment makes us live longer or feel better," said Dr Jeffrey S Borer, rocking-chair of the department of medicine and of cardiovascular medicine at the State University of New York (SUNY) Downstate Medical Center in New York City. This workroom only looked at "surrogates," import measures of heart function that might predict better future health in the patient.
So "This cannot be interpreted as if they instantly represent positive clinical outcomes. These certainly are reassuring stem cell data, but there's a great deal more to do before it is possible to know whether this is a viable therapy".
Another caveat: All the patients in this experimental were white Europeans. The study authors believe the results could be extrapolated to much of the US population, but not unavoidably to people who aren't white. Fat tissue yields many more stem-post cells than bone marrow (which has been studied before) and is much easier to access.
In bone marrow, 40 cubic centimeters (cc) typically revenue about 25000 stem cells, which is "not nearly enough to treat men and women with," said study author Dr Eric Duckers, head of the Molecular Cardiology Laboratory at Thoraxcenter, Erasmus University Medical Center in Rotterdam. To get enough cells to exert oneself with, those arrest cells would have to be cultured, a process that can take six to eight weeks.
Wednesday, 15 January 2020
Heart Risk For Elderly People Increases When Sleep Apnea
Heart Risk For Elderly People Increases When Sleep Apnea.
The snoring and breathing disturbances of beauty sleep apnea may be more than just a nuisance, with a late study linking the get to higher risks for heart failure and heart disease in middle-aged and older men. However, the deliberate over found no correlation between sleep apnea and coronary heart disease in women, or in men older than 70.
And "The vital here is that there is a lot of undiagnosed sleep apnea, and that, at least in men, it is associated with the phenomenon of coronary heart disease and heart failure. Only about 10 percent of catch forty winks apnea cases are diagnosed," said Dr Daniel Gottlieb, associate professor of medicine, Boston University School of Medicine. Gottlieb esteemed that while the jump in heart gamble was noteworthy, it was not as large as that seen in previous clinic-based studies of sleep apnea because the participants were drawn from a filthy community-based population.
According to background information in the study, sleep apnea sufferers awaken feverishly during the night struggling to breathe, often experiencing a shot of blood pressure- raising adrenaline. Most often, they go fist back to sleep, unaware of what happened. But the awakenings are repeated, sometimes up to 30 times an hour, depriving the sufferer of dynamic oxygen and sound sleep.
The research is published online July 12 in Circulation. In the study, almost 2000 men and about 2500 women - all released of verve problems at the beginning of the research - were recorded as they slept using polysomnograms, which premeditated the presence and severity of sleep apnea as calibrated on the Apnea-Hypopnea Index. About half had no symptoms of zizz apnea, the team found, while half had mild, moderate or severe symptoms.
Participants were then contacted at various times from 1998 to the irrevocable follow-up in April 2006. During that time, 473 cardiac events occurred, including 185 boldness attacks, 212 heart bypass operations, and 76 deaths. There were also 308 cases of centre failure; of these 144 people also had a nucleus attack.
The snoring and breathing disturbances of beauty sleep apnea may be more than just a nuisance, with a late study linking the get to higher risks for heart failure and heart disease in middle-aged and older men. However, the deliberate over found no correlation between sleep apnea and coronary heart disease in women, or in men older than 70.
And "The vital here is that there is a lot of undiagnosed sleep apnea, and that, at least in men, it is associated with the phenomenon of coronary heart disease and heart failure. Only about 10 percent of catch forty winks apnea cases are diagnosed," said Dr Daniel Gottlieb, associate professor of medicine, Boston University School of Medicine. Gottlieb esteemed that while the jump in heart gamble was noteworthy, it was not as large as that seen in previous clinic-based studies of sleep apnea because the participants were drawn from a filthy community-based population.
According to background information in the study, sleep apnea sufferers awaken feverishly during the night struggling to breathe, often experiencing a shot of blood pressure- raising adrenaline. Most often, they go fist back to sleep, unaware of what happened. But the awakenings are repeated, sometimes up to 30 times an hour, depriving the sufferer of dynamic oxygen and sound sleep.
The research is published online July 12 in Circulation. In the study, almost 2000 men and about 2500 women - all released of verve problems at the beginning of the research - were recorded as they slept using polysomnograms, which premeditated the presence and severity of sleep apnea as calibrated on the Apnea-Hypopnea Index. About half had no symptoms of zizz apnea, the team found, while half had mild, moderate or severe symptoms.
Participants were then contacted at various times from 1998 to the irrevocable follow-up in April 2006. During that time, 473 cardiac events occurred, including 185 boldness attacks, 212 heart bypass operations, and 76 deaths. There were also 308 cases of centre failure; of these 144 people also had a nucleus attack.
Wednesday, 8 January 2020
Treatment Of Heart Attack And Stroke In Certified Hospitals
Treatment Of Heart Attack And Stroke In Certified Hospitals.
Around the nation, hospitals pass on to themselves as "stroke centers of excellence" or "chest bore centers," the substance being those facilities offer top-notch care for stroke and heart attacks. But stylish programs for certifying, accrediting or recognizing hospitals as providers of the best cardiovascular or stroke care are falling short, according to an American Heart Association/American Stroke Association advisory. "Right now, it's not always sheer what is just a marketing duration and what actually truly distinguishes the quality of a center," said Dr Gregg Fonarow, an American Heart Association spokesman and professor of cardiovascular medication at the University of California, Los Angeles.
A look at of the available data found no clear relationship between having a festive designation as a heart attack or stroke care center and the care the hospitals provide or, even more important, how patients fare. To variation that, the American Heart Association and the American Stroke Association are jointly developing a inclusive stroke and cardiovascular care certification program that should go through as a national standard.
The goal is to help patients, insurers and others have more reliable data about where they are most likely to receive the most up-to-date, evidence-based care available. "There is a value to having a trusted origin develop a certification program that clinicians, insurers and the public can use to understand which hospitals are providing uncommon cardiovascular and stroke care, including achieving high-quality outcomes".
The program, which will take from about two years to develop and will likely be done in partnership with other major medical organizations, will cover exigency situations such as heart attack and stroke, but also heart failure management and coronary bypass surgery. The admonitory is published online Nov 12, 2010 and in the Dec 7, 2010 language issue of Circulation.
Typically, recognition and certification programs require that hospitals put certain procedures in place, but they don't praepostor how well hospitals are adhering to the practices or whether patient outcomes are improving precedent author of the advisory. And those are the better certification programs. Other self-proclaimed "centers of excellence" may unmistakably be terms dreamed up by marketing departments.
Around the nation, hospitals pass on to themselves as "stroke centers of excellence" or "chest bore centers," the substance being those facilities offer top-notch care for stroke and heart attacks. But stylish programs for certifying, accrediting or recognizing hospitals as providers of the best cardiovascular or stroke care are falling short, according to an American Heart Association/American Stroke Association advisory. "Right now, it's not always sheer what is just a marketing duration and what actually truly distinguishes the quality of a center," said Dr Gregg Fonarow, an American Heart Association spokesman and professor of cardiovascular medication at the University of California, Los Angeles.
A look at of the available data found no clear relationship between having a festive designation as a heart attack or stroke care center and the care the hospitals provide or, even more important, how patients fare. To variation that, the American Heart Association and the American Stroke Association are jointly developing a inclusive stroke and cardiovascular care certification program that should go through as a national standard.
The goal is to help patients, insurers and others have more reliable data about where they are most likely to receive the most up-to-date, evidence-based care available. "There is a value to having a trusted origin develop a certification program that clinicians, insurers and the public can use to understand which hospitals are providing uncommon cardiovascular and stroke care, including achieving high-quality outcomes".
The program, which will take from about two years to develop and will likely be done in partnership with other major medical organizations, will cover exigency situations such as heart attack and stroke, but also heart failure management and coronary bypass surgery. The admonitory is published online Nov 12, 2010 and in the Dec 7, 2010 language issue of Circulation.
Typically, recognition and certification programs require that hospitals put certain procedures in place, but they don't praepostor how well hospitals are adhering to the practices or whether patient outcomes are improving precedent author of the advisory. And those are the better certification programs. Other self-proclaimed "centers of excellence" may unmistakably be terms dreamed up by marketing departments.
Saturday, 4 January 2020
Prolonged Use Of Statins Does Not Increase The Risk Of Cancer
Prolonged Use Of Statins Does Not Increase The Risk Of Cancer.
New explore supports the general idea that patients who take cholesterol-lowering drugs known as statins may not have an increased hazard for cancer, as some previous studies suggested. Statins are the most commonly prescribed drugs for kith and kin with high blood cholesterol levels, which are linked to heart disease. Brand names number Crestor, Lipitor and Zocor. "Three or four years ago there was a broadening of articles pointing out that statins could produce cancer, and, at present, the most recent studies do not show this, and this is one of them," said Dr Valentin Fuster, by president of the American Heart Association and president of Mount Sinai Heart in New York City.
This latest study, slated for show Wednesday at the annual meeting of the American Heart Association in Chicago, was conducted by researchers from S2 Statistical Solutions, Inc, a ensemble that does economic research for health care-related businesses; the University of California, San Diego; and GE Healthcare, a allotment of General Electric, which provided the database for the study. Another just out study, reported Nov 10, 2010 at a assembly of the American Association for Cancer Research, also found that long-term use of statins did not increase the risk of cancer and might even dwindle users' risks for lymphoma, melanoma and endometrial tumors.
New explore supports the general idea that patients who take cholesterol-lowering drugs known as statins may not have an increased hazard for cancer, as some previous studies suggested. Statins are the most commonly prescribed drugs for kith and kin with high blood cholesterol levels, which are linked to heart disease. Brand names number Crestor, Lipitor and Zocor. "Three or four years ago there was a broadening of articles pointing out that statins could produce cancer, and, at present, the most recent studies do not show this, and this is one of them," said Dr Valentin Fuster, by president of the American Heart Association and president of Mount Sinai Heart in New York City.
This latest study, slated for show Wednesday at the annual meeting of the American Heart Association in Chicago, was conducted by researchers from S2 Statistical Solutions, Inc, a ensemble that does economic research for health care-related businesses; the University of California, San Diego; and GE Healthcare, a allotment of General Electric, which provided the database for the study. Another just out study, reported Nov 10, 2010 at a assembly of the American Association for Cancer Research, also found that long-term use of statins did not increase the risk of cancer and might even dwindle users' risks for lymphoma, melanoma and endometrial tumors.
Saturday, 28 December 2019
The Risk Of Heart Attack Or A Stroke Doubles With Diabetes
The Risk Of Heart Attack Or A Stroke Doubles With Diabetes.
Diabetes appears to doubled the endanger of dying from a heart attack, swipe or other heart condition, a new study finds. The researchers implicate diabetes in one of every 10 deaths from cardiovascular disease, or about 325000 deaths a year in industrialized countries. "We have known for decades that kinfolk with diabetes are more apt to to have heart attacks," said researcher Nadeem Sarwar, a lecturer in cardiovascular epidemiology at the University of Cambridge in England.
But "In spitefulness of decades of research, several questions have persisted as to how much higher this peril is, whether it's explained by things we already know of, and whether the jeopardy is different in different people". These findings highlight the need to prevent and handle diabetes, a disease in which blood sugar levels are too high.
The report is published in the June 26 flow of The Lancet, and Sarwar plans to present the findings at the American Diabetes Association's meeting, June 25 to 29 in Orlando, Fla. For the study, Sarwar's pair at ease data on 698,782 people who participated in an international consortium. The participants were followed for 10 years through 102 surveys done in 25 countries.
The researchers found that having diabetes nearly doubled the jeopardize of misery from various diseases involving the heart and blood vessels. But this risk was only partially due to the usual culprits - cholesterol, blood apply pressure and obesity.
Diabetes appears to doubled the endanger of dying from a heart attack, swipe or other heart condition, a new study finds. The researchers implicate diabetes in one of every 10 deaths from cardiovascular disease, or about 325000 deaths a year in industrialized countries. "We have known for decades that kinfolk with diabetes are more apt to to have heart attacks," said researcher Nadeem Sarwar, a lecturer in cardiovascular epidemiology at the University of Cambridge in England.
But "In spitefulness of decades of research, several questions have persisted as to how much higher this peril is, whether it's explained by things we already know of, and whether the jeopardy is different in different people". These findings highlight the need to prevent and handle diabetes, a disease in which blood sugar levels are too high.
The report is published in the June 26 flow of The Lancet, and Sarwar plans to present the findings at the American Diabetes Association's meeting, June 25 to 29 in Orlando, Fla. For the study, Sarwar's pair at ease data on 698,782 people who participated in an international consortium. The participants were followed for 10 years through 102 surveys done in 25 countries.
The researchers found that having diabetes nearly doubled the jeopardize of misery from various diseases involving the heart and blood vessels. But this risk was only partially due to the usual culprits - cholesterol, blood apply pressure and obesity.
Friday, 27 December 2019
Austrian Scientists Have Determined The Effect Of Morphine On Blood Coagulation
Austrian Scientists Have Determined The Effect Of Morphine On Blood Coagulation.
Morphine appears to diet the effectiveness of the commonly reach-me-down blood-thinning narcotize Plavix, which could hamper emergency-room efforts to treat heart attack victims, Austrian researchers report. The verdict could create serious dilemmas in the ER, where doctors have to weigh a centre patient's intense pain against the need to break up and prevent blood clots, said Dr Deepak Bhatt, foreman director of interventional cardiovascular programs at Brigham and Women's Hospital Heart and Vascular Center, in Boston. "If a serene is having crushing heart pain, you can't just determine them to tough it out, and morphine is the most commonly used medication in that situation," said Bhatt, who was not affected in the study.
And "Giving them morphine is the humane thing to do, but it could also create delays in care". Doctors will have to be very careful if a heart attack patient needs to have a stent implanted. Blood thinners are severe in preventing blood clots from forming around the stent. "If that predicament is unfolding, it requires a little bit of extra thought on the part of the physician whether they want to give that full slug of morphine or not".
About half of the 600000 stent procedures that make use of place in the United States each year befall as the result of a heart attack, angina or other acute coronary syndrome. The Austrian researchers focused on 24 in good people who received either a dose of Plavix with an injection of morphine or a placebo drug. Morphine delayed the wit of Plavix (clopidogrel) to thin a patient's blood by an ordinary of two hours, the researchers said.
Morphine appears to diet the effectiveness of the commonly reach-me-down blood-thinning narcotize Plavix, which could hamper emergency-room efforts to treat heart attack victims, Austrian researchers report. The verdict could create serious dilemmas in the ER, where doctors have to weigh a centre patient's intense pain against the need to break up and prevent blood clots, said Dr Deepak Bhatt, foreman director of interventional cardiovascular programs at Brigham and Women's Hospital Heart and Vascular Center, in Boston. "If a serene is having crushing heart pain, you can't just determine them to tough it out, and morphine is the most commonly used medication in that situation," said Bhatt, who was not affected in the study.
And "Giving them morphine is the humane thing to do, but it could also create delays in care". Doctors will have to be very careful if a heart attack patient needs to have a stent implanted. Blood thinners are severe in preventing blood clots from forming around the stent. "If that predicament is unfolding, it requires a little bit of extra thought on the part of the physician whether they want to give that full slug of morphine or not".
About half of the 600000 stent procedures that make use of place in the United States each year befall as the result of a heart attack, angina or other acute coronary syndrome. The Austrian researchers focused on 24 in good people who received either a dose of Plavix with an injection of morphine or a placebo drug. Morphine delayed the wit of Plavix (clopidogrel) to thin a patient's blood by an ordinary of two hours, the researchers said.
Saturday, 21 December 2019
Newer Blood Thinner Brilinta Exceeds Plavix For Cardiac Bypass Surgery Patients
Newer Blood Thinner Brilinta Exceeds Plavix For Cardiac Bypass Surgery Patients.
In a examination comparing two anti-clotting drugs, patients given Brilinta before cardiac get round surgery were less qualified to die than those given Plavix, researchers found. Both drugs restrain platelets from clumping and forming clots, but Plavix, the more popular drug, has been linked to potentially treacherous side effects in cancer patients.
In addition, some people don't metabolize it well, making it less effective. "We did perceive about a 50 percent reduction in mortality in these patients, who took Brilinta, but without any further in bleeding complications," Dr Claes Held, an associate professor of cardiology at the Uppsala Clinical Research Center at Uppsala University in Sweden and the study's clue researcher, said during an afternoon cleave to conference Tuesday.
So "Ticagrelor (Brilinta) in this setting, with acute coronary syndrome patients with the likely need for bypass surgery, is more effective than clopidogrel (Plavix) in preventing cardiovascular and thorough mortality without increasing the risk of bleeding". A danger with any anti-platelet hypnotic is the risk of uncontrolled bleeding, which is why these drugs are stopped before patients undergo surgery.
Held was scheduled to acquaint with the results Tuesday at the American College of Cardiology's annual meeting in Atlanta. For the study, Held and colleagues looked at a subgroup of 1261 patients in the Platelet Inhibition and Patient Outcomes (PLATO) trial. The researchers found that 10,5 percent of the patients given Brilinta with an increment of aspirin before surgery had a heartlessness attack, work or died from heart disease within a week after surgery. Among patients given Plavix profit aspirin, 12,6 percent had the same adverse outcomes.
Patients taking Brilinta had a unqualified death rate of 4,6 percent, compared with 9,2 percent for patients taking Plavix. In addition, the cardiovascular extirpation rates were 4 percent among patients taking Brilinta and 7,5 percent amidst those taking Plavix. When Held's team looked at each group individually, they found no statistically significant characteristic for heart attack and stroke and no significant difference in major bleeding from the bypass operation itself. The two drugs farm in different ways.
In a examination comparing two anti-clotting drugs, patients given Brilinta before cardiac get round surgery were less qualified to die than those given Plavix, researchers found. Both drugs restrain platelets from clumping and forming clots, but Plavix, the more popular drug, has been linked to potentially treacherous side effects in cancer patients.
In addition, some people don't metabolize it well, making it less effective. "We did perceive about a 50 percent reduction in mortality in these patients, who took Brilinta, but without any further in bleeding complications," Dr Claes Held, an associate professor of cardiology at the Uppsala Clinical Research Center at Uppsala University in Sweden and the study's clue researcher, said during an afternoon cleave to conference Tuesday.
So "Ticagrelor (Brilinta) in this setting, with acute coronary syndrome patients with the likely need for bypass surgery, is more effective than clopidogrel (Plavix) in preventing cardiovascular and thorough mortality without increasing the risk of bleeding". A danger with any anti-platelet hypnotic is the risk of uncontrolled bleeding, which is why these drugs are stopped before patients undergo surgery.
Held was scheduled to acquaint with the results Tuesday at the American College of Cardiology's annual meeting in Atlanta. For the study, Held and colleagues looked at a subgroup of 1261 patients in the Platelet Inhibition and Patient Outcomes (PLATO) trial. The researchers found that 10,5 percent of the patients given Brilinta with an increment of aspirin before surgery had a heartlessness attack, work or died from heart disease within a week after surgery. Among patients given Plavix profit aspirin, 12,6 percent had the same adverse outcomes.
Patients taking Brilinta had a unqualified death rate of 4,6 percent, compared with 9,2 percent for patients taking Plavix. In addition, the cardiovascular extirpation rates were 4 percent among patients taking Brilinta and 7,5 percent amidst those taking Plavix. When Held's team looked at each group individually, they found no statistically significant characteristic for heart attack and stroke and no significant difference in major bleeding from the bypass operation itself. The two drugs farm in different ways.
Wednesday, 18 December 2019
Cardiologists Recommend To Monitor Blood Pressure
Cardiologists Recommend To Monitor Blood Pressure.
Fewer commoners should bear medicine to control their high blood pressure, a new set of guidelines recommends. Adults superannuated 60 or older should only take blood pressure medication if their blood pressure exceeds 150/90, which sets a higher sandbank for treatment than the current guideline of 140/90, according to the report, published online Dec 18, 2013 in the Journal of the American Medical Association. The virtuoso panel that crafted the guidelines also recommends that diabetes and kidney patients younger than 60 be treated at the same period as Dick else that age, when their blood pressure exceeds 140/90.
Until now, people with those chronic conditions have been prescribed medication when their blood persuasion reading topped 130/80. Blood pressure is the might exerted on the inner walls of blood vessels as the heart pumps blood to all parts of the body. The more elevated reading, known as the systolic pressure, measures that force as the heart contracts and pushes blood out of its chambers. The discount reading, known as diastolic pressure, measures that constrain as the heart relaxes between contractions.
Adult blood pressure is considered normal at 120/80. The recommendations are based on clinical validation showing that stricter guidelines provided no additional advantage to patients, explained guidelines author Dr Paul James, head of the department of dynasty medicine at the University of Iowa Carver College of Medicine. "We really couldn't walk additional health benefits by driving blood pressure lower than 150 in people over 60 years of stage ".
And "It was very clear that 150 was the best number". The American Heart Association (AHA) and the American College of Cardiology (ACC) did not analysis the new guidelines, but the AHA has expressed reservations about the panel's conclusions. "We are active that relaxing the recommendations may expose more persons to the fine kettle of fish of inadequately controlled blood pressure," said AHA president-elect Dr Elliott Antman, a cardiologist at Brigham and Women's Hospital and a professor at Harvard Medical School in Boston.
In November, the AHA and ACC released their own seam set of therapy guidelines for high blood pressure, as well as inexperienced guidelines for the treatment of high cholesterol that could greatly expand the number of race taking cholesterol-lowering statins. About one in three adults in the United States has high blood pressure, according to the US National Heart, Lung, and Blood Institute. The introduce formed the Eighth Joint National Committee, or JNC 8, in 2008 to update the termination set of high blood demand treatment guidelines, which were issued in 2003.
In June 2013, the institute announced that it would no longer participate in the condition of any clinical guidelines, including the blood pressure guidelines nearing completion. However, the disclosure came after the institute had reviewed the preliminary JNC 8 findings. The JNC 8 solid to forge ahead and finish the guidelines.
Fewer commoners should bear medicine to control their high blood pressure, a new set of guidelines recommends. Adults superannuated 60 or older should only take blood pressure medication if their blood pressure exceeds 150/90, which sets a higher sandbank for treatment than the current guideline of 140/90, according to the report, published online Dec 18, 2013 in the Journal of the American Medical Association. The virtuoso panel that crafted the guidelines also recommends that diabetes and kidney patients younger than 60 be treated at the same period as Dick else that age, when their blood pressure exceeds 140/90.
Until now, people with those chronic conditions have been prescribed medication when their blood persuasion reading topped 130/80. Blood pressure is the might exerted on the inner walls of blood vessels as the heart pumps blood to all parts of the body. The more elevated reading, known as the systolic pressure, measures that force as the heart contracts and pushes blood out of its chambers. The discount reading, known as diastolic pressure, measures that constrain as the heart relaxes between contractions.
Adult blood pressure is considered normal at 120/80. The recommendations are based on clinical validation showing that stricter guidelines provided no additional advantage to patients, explained guidelines author Dr Paul James, head of the department of dynasty medicine at the University of Iowa Carver College of Medicine. "We really couldn't walk additional health benefits by driving blood pressure lower than 150 in people over 60 years of stage ".
And "It was very clear that 150 was the best number". The American Heart Association (AHA) and the American College of Cardiology (ACC) did not analysis the new guidelines, but the AHA has expressed reservations about the panel's conclusions. "We are active that relaxing the recommendations may expose more persons to the fine kettle of fish of inadequately controlled blood pressure," said AHA president-elect Dr Elliott Antman, a cardiologist at Brigham and Women's Hospital and a professor at Harvard Medical School in Boston.
In November, the AHA and ACC released their own seam set of therapy guidelines for high blood pressure, as well as inexperienced guidelines for the treatment of high cholesterol that could greatly expand the number of race taking cholesterol-lowering statins. About one in three adults in the United States has high blood pressure, according to the US National Heart, Lung, and Blood Institute. The introduce formed the Eighth Joint National Committee, or JNC 8, in 2008 to update the termination set of high blood demand treatment guidelines, which were issued in 2003.
In June 2013, the institute announced that it would no longer participate in the condition of any clinical guidelines, including the blood pressure guidelines nearing completion. However, the disclosure came after the institute had reviewed the preliminary JNC 8 findings. The JNC 8 solid to forge ahead and finish the guidelines.
Thursday, 12 December 2019
The Use Of Red Meat Can Lead To Atherosclerosis
The Use Of Red Meat Can Lead To Atherosclerosis.
A parasynthesis found in red vital part and added as a supplement to popular energy drinks promotes hardening and clogging of the arteries, otherwise known as atherosclerosis, a fresh study suggests April 2013. Researchers conjecture that bacteria in the digestive tract convert the compound, called carnitine, into trimethylamine-N-oxide (TMAO). Previous investigating by the same team of Cleveland Clinic investigators found that TMAO promotes atherosclerosis in people. And there was an another twist: The workroom also found that a diet high in carnitine encourages the flowering of the bacteria that metabolize the compound, leading to even higher TMAO production.
The type of bacteria living in our digestive tracts are dictated by our long-term dietary patterns. A council high in carnitine absolutely shifts our gut microbe composition to those that like carnitine, making meat eaters even more reachable to forming TMAO and its artery-clogging effects," study leader Dr Stanley Hazen, chairwoman of preventive cardiology and rehabilitation in Cleveland Clinic's Heart and Vascular Institute, said in a clinic dirt release. Hazen's team looked at nearly 2600 patients undergoing sincerity evaluations.
The researchers found that consistently high carnitine levels were associated with a raised risk of soul disease, heart attack, stroke and heart-related death. They also found that TMAO levels were much deign among vegetarians and vegans than among people with unrestricted diets (omnivores). Vegetarians do not consume meat while vegans do not eat any animal products, including eggs and dairy.
A parasynthesis found in red vital part and added as a supplement to popular energy drinks promotes hardening and clogging of the arteries, otherwise known as atherosclerosis, a fresh study suggests April 2013. Researchers conjecture that bacteria in the digestive tract convert the compound, called carnitine, into trimethylamine-N-oxide (TMAO). Previous investigating by the same team of Cleveland Clinic investigators found that TMAO promotes atherosclerosis in people. And there was an another twist: The workroom also found that a diet high in carnitine encourages the flowering of the bacteria that metabolize the compound, leading to even higher TMAO production.
The type of bacteria living in our digestive tracts are dictated by our long-term dietary patterns. A council high in carnitine absolutely shifts our gut microbe composition to those that like carnitine, making meat eaters even more reachable to forming TMAO and its artery-clogging effects," study leader Dr Stanley Hazen, chairwoman of preventive cardiology and rehabilitation in Cleveland Clinic's Heart and Vascular Institute, said in a clinic dirt release. Hazen's team looked at nearly 2600 patients undergoing sincerity evaluations.
The researchers found that consistently high carnitine levels were associated with a raised risk of soul disease, heart attack, stroke and heart-related death. They also found that TMAO levels were much deign among vegetarians and vegans than among people with unrestricted diets (omnivores). Vegetarians do not consume meat while vegans do not eat any animal products, including eggs and dairy.
Wednesday, 11 December 2019
A Significant Reduction In The Number Of Heart Attacks And Reduce Mortality In Northern California
A Significant Reduction In The Number Of Heart Attacks And Reduce Mortality In Northern California.
In the make against basics disease, here's some terrific news from the front lines: A large study reports a 24 percent dwindle in heart attacks and a significant reduction in deaths since 1999 in one northern California population. The most portentous finding in the study of more than 46000 hospitalizations between 1999 and 2008 is a striking reduction in the most sober form of heart attacks, known as STEMI, said Dr Alan S Go, a chief of the study reported in the June 10 issue of the New England Journal of Medicine. "The relevant incidence of STEMI went down by 62 percent in the past decade," said Go, top dog of the Comprehensive Clinical Research Unit at Kaiser Permanente, one of the nation's largest not-for-profit health-care providers.
STEMI (segment uplifting myocardial infarction) is an acronym derived from the electrocardiogram gauge of the most severe heart attacks, the ones mostly likely to cause permanent disability or death. Myocardial infarction is the routine medical term for a heart attack.
Because of the decrease in heart attack deaths, middle disease is no longer the leading cause of death among the northern California residents enrolled in the Permanente Medical Group, said Dr Robert Pearl, leadership director of the group. Nationwide, nature disease has been the leading cause of American deaths for decades. In the group, it is now newer to cancer.
The report offers an example of what a highly organized, technologically advanced health-care sketch can accomplish. "If every American got the same level of care, we would avoid 200000 heart attacks and rap deaths in this country every year. The numbers in the report are definitely credible and are consistent with the trends we are in elsewhere," said Dr Michael Lauer, director of the division of cardiovascular sciences at the US National Heart, Lung, and Blood Institute.
A enumerate of registries have looked at sympathy disease outcomes for decades, "and we have seen since the 1990s a consistent and persistent fall in deaths from compassion disease. We see the same pattern in just about every group," and the Kaiser Permanente report presents "highly able-bodied data" about the reduction in heart attacks and the deaths they cause.
In the make against basics disease, here's some terrific news from the front lines: A large study reports a 24 percent dwindle in heart attacks and a significant reduction in deaths since 1999 in one northern California population. The most portentous finding in the study of more than 46000 hospitalizations between 1999 and 2008 is a striking reduction in the most sober form of heart attacks, known as STEMI, said Dr Alan S Go, a chief of the study reported in the June 10 issue of the New England Journal of Medicine. "The relevant incidence of STEMI went down by 62 percent in the past decade," said Go, top dog of the Comprehensive Clinical Research Unit at Kaiser Permanente, one of the nation's largest not-for-profit health-care providers.
STEMI (segment uplifting myocardial infarction) is an acronym derived from the electrocardiogram gauge of the most severe heart attacks, the ones mostly likely to cause permanent disability or death. Myocardial infarction is the routine medical term for a heart attack.
Because of the decrease in heart attack deaths, middle disease is no longer the leading cause of death among the northern California residents enrolled in the Permanente Medical Group, said Dr Robert Pearl, leadership director of the group. Nationwide, nature disease has been the leading cause of American deaths for decades. In the group, it is now newer to cancer.
The report offers an example of what a highly organized, technologically advanced health-care sketch can accomplish. "If every American got the same level of care, we would avoid 200000 heart attacks and rap deaths in this country every year. The numbers in the report are definitely credible and are consistent with the trends we are in elsewhere," said Dr Michael Lauer, director of the division of cardiovascular sciences at the US National Heart, Lung, and Blood Institute.
A enumerate of registries have looked at sympathy disease outcomes for decades, "and we have seen since the 1990s a consistent and persistent fall in deaths from compassion disease. We see the same pattern in just about every group," and the Kaiser Permanente report presents "highly able-bodied data" about the reduction in heart attacks and the deaths they cause.
Sunday, 8 December 2019
Shoveling Snow Leads To Death
Shoveling Snow Leads To Death.
Shoveling snow can snowball your imperil of heart attack, and you should take precautions to protect yourself, an expert says. "When the temperature front drops, our blood vessels narrow to prevent our bodies from losing heat," Dr Holly Andersen, gaffer of education and outreach at the Ronald O Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center, said in a dispensary news release. "This is a fool response that can also put people with heart conditions and those involved in strenuous exercise at greater peril of having a heart attack".
Andersen said shoveling snow is one of the most strenuous and dangerous winter activities. It can leg up blood pressure and, combined with the effects of frigid temperatures, can significantly proliferate heart attack risk. Andersen offered the following advice for safe shoveling and good courage health this winter.
Shoveling snow can snowball your imperil of heart attack, and you should take precautions to protect yourself, an expert says. "When the temperature front drops, our blood vessels narrow to prevent our bodies from losing heat," Dr Holly Andersen, gaffer of education and outreach at the Ronald O Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center, said in a dispensary news release. "This is a fool response that can also put people with heart conditions and those involved in strenuous exercise at greater peril of having a heart attack".
Andersen said shoveling snow is one of the most strenuous and dangerous winter activities. It can leg up blood pressure and, combined with the effects of frigid temperatures, can significantly proliferate heart attack risk. Andersen offered the following advice for safe shoveling and good courage health this winter.
Friday, 6 December 2019
Treatment Of Diabetes Is Different For Men And Women
Treatment Of Diabetes Is Different For Men And Women.
Widely hand-me-down diabetes drugs have particular effects on men's and women's hearts, a rejuvenated study suggests. Researchers examined how three commonly prescribed treatments for type 2 diabetes laid hold of 78 patients who were divided into three groups. One group took metformin alone, the subsequent group took metformin plus rosiglitazone (sold under the maker name Avandia) and the third group took metformin plus Lovaza, a type of fish oil. Metformin reduces blood sugar assembly by the liver and improves insulin sensitivity.
Rosiglitazone also improves insulin consciousness and moves free fatty acids out of the blood. Lovaza lowers blood levels of another classification of fat called triglycerides. The researchers found that the drugs had very several and sometimes opposite effects on the hearts of men and women, even as the drugs controlled blood sugar equally well in both genders. The reading appears in the December issue of the American Journal of Physiology - Heart and Circulatory Physiology.
Widely hand-me-down diabetes drugs have particular effects on men's and women's hearts, a rejuvenated study suggests. Researchers examined how three commonly prescribed treatments for type 2 diabetes laid hold of 78 patients who were divided into three groups. One group took metformin alone, the subsequent group took metformin plus rosiglitazone (sold under the maker name Avandia) and the third group took metformin plus Lovaza, a type of fish oil. Metformin reduces blood sugar assembly by the liver and improves insulin sensitivity.
Rosiglitazone also improves insulin consciousness and moves free fatty acids out of the blood. Lovaza lowers blood levels of another classification of fat called triglycerides. The researchers found that the drugs had very several and sometimes opposite effects on the hearts of men and women, even as the drugs controlled blood sugar equally well in both genders. The reading appears in the December issue of the American Journal of Physiology - Heart and Circulatory Physiology.
Thursday, 5 December 2019
High Level Of Cardiac Troponin In The Blood Indicates A High Risk Of Heart Disease
High Level Of Cardiac Troponin In The Blood Indicates A High Risk Of Heart Disease.
The spirit of a undeniable biomarker in the blood is associated with structural boldness disease and increased risk of death from all causes, a altered study suggests. It goes by the name of cardiac troponin T (cTnT) - a heart-specific protein that serves as a biomarker for diagnosing enthusiasm attack. In addition, elevated cTnT levels are associated with a tons of chronic diseases such as coronary artery disease (CAD), humanity failure, and chronic kidney disease, according to background information in the study.
And "Recently, a highly reactive assay (test) for cTnT has been developed that detects levels approximately 10-fold lower than those detectable with the ordinary assay," wrote Dr James A de Lemos, of the University of Texas Southwestern Medical Center in Dallas, and colleagues. "In patients with continuing heart failure and confirmed CAD, circulating cTnT is detectable in almost all individuals with the highly sensitive assay, and higher levels correlate strongly with increased cardiovascular mortality".
In this study, the researchers second-hand the highly receptive test and the standard test to measure cTnT levels in 3546 people, aged 30 to 65, in Dallas County. The mastery of detectable cTnT among the participants was 25 percent using the praisefully sensitive test and 0,7 percent using the standard test.
The spirit of a undeniable biomarker in the blood is associated with structural boldness disease and increased risk of death from all causes, a altered study suggests. It goes by the name of cardiac troponin T (cTnT) - a heart-specific protein that serves as a biomarker for diagnosing enthusiasm attack. In addition, elevated cTnT levels are associated with a tons of chronic diseases such as coronary artery disease (CAD), humanity failure, and chronic kidney disease, according to background information in the study.
And "Recently, a highly reactive assay (test) for cTnT has been developed that detects levels approximately 10-fold lower than those detectable with the ordinary assay," wrote Dr James A de Lemos, of the University of Texas Southwestern Medical Center in Dallas, and colleagues. "In patients with continuing heart failure and confirmed CAD, circulating cTnT is detectable in almost all individuals with the highly sensitive assay, and higher levels correlate strongly with increased cardiovascular mortality".
In this study, the researchers second-hand the highly receptive test and the standard test to measure cTnT levels in 3546 people, aged 30 to 65, in Dallas County. The mastery of detectable cTnT among the participants was 25 percent using the praisefully sensitive test and 0,7 percent using the standard test.
Tuesday, 3 December 2019
This Is The First Trial Of Gene Therapy For Patients With Heart Failure
This Is The First Trial Of Gene Therapy For Patients With Heart Failure.
By substituting a thriving gene for a flawed one, scientists were able to restrictedly restore the heart's ability to pump in 39 heart failure patients, researchers report. "This is the anything else time gene therapy has been tested and shown to improve outcomes for patients with advanced pith failure," study lead author Dr Donna Mancini, professor of c physic and the Sudhir Choudhrie professor of cardiology at Columbia University College of Physicians and Surgeons in New York City, said in a university scuttlebutt release. "The psychotherapy works by replenishing levels of an enzyme necessary for the heart to pump more efficiently by introducing the gene for SERCA2a, which is depressed in these patients.
If these results are confirmed in time to come trials, this approach could be an alternative to kindliness transplant for patients without any other options". Mancini presented the results Monday at the annual meeting of the American Heart Association (AHA) in Chicago. The gene for SERCA2a raises levels of the enzyme back to where the tenderness can push more efficiently.
The enzyme regulates calcium cycling, which, in turn, is complicated in how well the heart contracts, the researchers said. "Heart failure is a defect in contractility related to calcium cycling," explained Dr Robert Eckel, defunct president of the AHA and professor of medication at the University of Colorado Denver.
By substituting a thriving gene for a flawed one, scientists were able to restrictedly restore the heart's ability to pump in 39 heart failure patients, researchers report. "This is the anything else time gene therapy has been tested and shown to improve outcomes for patients with advanced pith failure," study lead author Dr Donna Mancini, professor of c physic and the Sudhir Choudhrie professor of cardiology at Columbia University College of Physicians and Surgeons in New York City, said in a university scuttlebutt release. "The psychotherapy works by replenishing levels of an enzyme necessary for the heart to pump more efficiently by introducing the gene for SERCA2a, which is depressed in these patients.
If these results are confirmed in time to come trials, this approach could be an alternative to kindliness transplant for patients without any other options". Mancini presented the results Monday at the annual meeting of the American Heart Association (AHA) in Chicago. The gene for SERCA2a raises levels of the enzyme back to where the tenderness can push more efficiently.
The enzyme regulates calcium cycling, which, in turn, is complicated in how well the heart contracts, the researchers said. "Heart failure is a defect in contractility related to calcium cycling," explained Dr Robert Eckel, defunct president of the AHA and professor of medication at the University of Colorado Denver.
Overweight Often Leads To An Increase In Cholesterol And Diabetes
Overweight Often Leads To An Increase In Cholesterol And Diabetes.
Advances in medical method have made it easier than ever to trim dangerous cholesterol levels. A grade of cholesterol-lowering drugs known as statins have proven particularly effective, reducing the endanger for heart-related death by as much as 40 percent in people who have already suffered a heart attack, said Dr Vincent Bufalino, president and leading executive of Midwest Heart Specialists and a spokesman for the American Heart Association. "People have said we extremity them in the drinking water because they are just so effective in lowering cholesterol".
But he and other doctors on guard that when it comes to controlling cholesterol and enjoying overall health, nothing beats lifestyle changes, such as a heart-friendly victuals and regular exercise. "Once we became a fast-food generation, it's just too serene to order it at the first window, pick it up at the second window and eat it on the way to soccer. We paucity to get you to change now or you're going to end up as one of these statistics".
Folks with high cholesterol often are overweight, and if they deal with their cholesterol through medication only, they depart themselves open to such other chronic health problems as diabetes, high blood urge and arthritis, said Alice Lichtenstein, director and senior scientist at the Cardiovascular Nutrition Laboratory of the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University in Medford, Mass. The design of controlling cholesterol solely through medication is "an wretched implication of view".
And "There are a lot of other factors, especially when it comes to body weight, that the medications won't help. The aim that 'I'll just take medications' isn't a very healthy option, especially for the long term". That spike of view seems to be bolstered by new evidence that using cholesterol-lowering drugs won't by definition help a person who hopes to avoid heart disease.
British researchers who pooled and re-analyzed evidence from 11 cardiovascular studies found that taking statins did not reduce cardiac deaths among people who had not developed callousness disease. The finding has been questioned, however, by some medical experts, who note that the research did secure an overall reduction in cholesterol levels linked to statin use. "I have to tell you that belies a lot of the other science," Bufalino said of the study.
High cholesterol is strongly connected to cardiovascular disease, which is the supreme cause of ruin in the United States, according to the American Heart Association. Nearly 2300 Americans die of cardiovascular cancer each day - an average of one death every 38 seconds.
Cholesterol, which is a waxy substance, occurs to be sure in the human body. In fact, the body produces about 75 percent of the cholesterol needed to execute important tasks, which include building cell walls, creating hormones, processing vitamin D and producing bile acids that tolerate fats, according to the US National Institutes of Health.
Advances in medical method have made it easier than ever to trim dangerous cholesterol levels. A grade of cholesterol-lowering drugs known as statins have proven particularly effective, reducing the endanger for heart-related death by as much as 40 percent in people who have already suffered a heart attack, said Dr Vincent Bufalino, president and leading executive of Midwest Heart Specialists and a spokesman for the American Heart Association. "People have said we extremity them in the drinking water because they are just so effective in lowering cholesterol".
But he and other doctors on guard that when it comes to controlling cholesterol and enjoying overall health, nothing beats lifestyle changes, such as a heart-friendly victuals and regular exercise. "Once we became a fast-food generation, it's just too serene to order it at the first window, pick it up at the second window and eat it on the way to soccer. We paucity to get you to change now or you're going to end up as one of these statistics".
Folks with high cholesterol often are overweight, and if they deal with their cholesterol through medication only, they depart themselves open to such other chronic health problems as diabetes, high blood urge and arthritis, said Alice Lichtenstein, director and senior scientist at the Cardiovascular Nutrition Laboratory of the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University in Medford, Mass. The design of controlling cholesterol solely through medication is "an wretched implication of view".
And "There are a lot of other factors, especially when it comes to body weight, that the medications won't help. The aim that 'I'll just take medications' isn't a very healthy option, especially for the long term". That spike of view seems to be bolstered by new evidence that using cholesterol-lowering drugs won't by definition help a person who hopes to avoid heart disease.
British researchers who pooled and re-analyzed evidence from 11 cardiovascular studies found that taking statins did not reduce cardiac deaths among people who had not developed callousness disease. The finding has been questioned, however, by some medical experts, who note that the research did secure an overall reduction in cholesterol levels linked to statin use. "I have to tell you that belies a lot of the other science," Bufalino said of the study.
High cholesterol is strongly connected to cardiovascular disease, which is the supreme cause of ruin in the United States, according to the American Heart Association. Nearly 2300 Americans die of cardiovascular cancer each day - an average of one death every 38 seconds.
Cholesterol, which is a waxy substance, occurs to be sure in the human body. In fact, the body produces about 75 percent of the cholesterol needed to execute important tasks, which include building cell walls, creating hormones, processing vitamin D and producing bile acids that tolerate fats, according to the US National Institutes of Health.
Monday, 2 December 2019
Blueberries And Strawberries To Reduce The Risk Of Heart Attack
Blueberries And Strawberries To Reduce The Risk Of Heart Attack.
Eating three or more servings of blueberries and strawberries each week may staff downgrade a woman's peril of heart attack, a large new study suggests. The study included nearly 94000 infantile and middle-aged women who took part in the Nurses' Health Study II. The women completed questionnaires about their aliment every four years for 18 years. During the workroom period, 405 participants had heart attacks. Women who ate the most blueberries and strawberries were 32 percent less favourite to have a heart attack, compared to women who ate berries once a month or less.
This held steady even among women who ate a diet rich in other fruits and vegetables. This aid was independent of other heart risk factors such as advancing age, high blood pressure, folks history of heart attack, body mass index, exercise, smoking, and caffeine and spirits intake. The findings appear online Jan 14, 2013 in the journal Circulation.
The learn can't say specifically what about the berries seemed to result in a lower risk of heart denigrate among these women, or that there was a direct cause-and-effect link between eating the berries and lowered heart set risk. But blueberries and strawberries contain high levels of compounds that may help add to arteries, which counters plaque buildup, the researchers said.
Heart attacks can occur when plaque blocks blood ripple to the heart. "Berries were the most commonly consumed sources of these substances in the US diet, and they are one of the best sources of these dynamic bioactive compounds," said study lead author Aedin Cassidy. "These substances, called anthocyanins - a flavonoid - are plainly present in red- and blue-colored fruits and vegetables, so they are also found in ripe amounts in cherries, grapes, eggplant, black currants, plums and other berries".
Eating three or more servings of blueberries and strawberries each week may staff downgrade a woman's peril of heart attack, a large new study suggests. The study included nearly 94000 infantile and middle-aged women who took part in the Nurses' Health Study II. The women completed questionnaires about their aliment every four years for 18 years. During the workroom period, 405 participants had heart attacks. Women who ate the most blueberries and strawberries were 32 percent less favourite to have a heart attack, compared to women who ate berries once a month or less.
This held steady even among women who ate a diet rich in other fruits and vegetables. This aid was independent of other heart risk factors such as advancing age, high blood pressure, folks history of heart attack, body mass index, exercise, smoking, and caffeine and spirits intake. The findings appear online Jan 14, 2013 in the journal Circulation.
The learn can't say specifically what about the berries seemed to result in a lower risk of heart denigrate among these women, or that there was a direct cause-and-effect link between eating the berries and lowered heart set risk. But blueberries and strawberries contain high levels of compounds that may help add to arteries, which counters plaque buildup, the researchers said.
Heart attacks can occur when plaque blocks blood ripple to the heart. "Berries were the most commonly consumed sources of these substances in the US diet, and they are one of the best sources of these dynamic bioactive compounds," said study lead author Aedin Cassidy. "These substances, called anthocyanins - a flavonoid - are plainly present in red- and blue-colored fruits and vegetables, so they are also found in ripe amounts in cherries, grapes, eggplant, black currants, plums and other berries".
Labels:
berries,
blueberries,
heart,
strawberries,
study,
women
Saturday, 30 November 2019
Fibrosis Of The Heart Muscle Can Lead To Sudden Death
Fibrosis Of The Heart Muscle Can Lead To Sudden Death.
Scarring in the heart's impediment may be a indicator risk factor for death, and scans that reckon the amount of scarring might help in deciding which patients need particular treatments, a new turn over suggests. At issue is a kind of scarring, or fibrosis, known as midwall fibrosis. Reporting in the March 6 exit of the Journal of the American Medical Association, researchers found that patients with enlarged hearts who had more of this strain of damage were more than five times more likely to experience sudden cardiac extermination compared to patients without such scarring. "Both the presence of fibrosis and the extent were independently and incrementally associated with all-cause mortality passing ," concluded a team led by Dr Ankur Gulati of Royal Brompton Hospital, in London.
In the study, the researchers took high-tech MRI scans of the hearts of 472 patients with dilated cardiomyopathy, a material of weakened and enlarged goodness that is often linked to consideration failure. The MRIs looked for scarring in the middle section of the heart muscle wall. Tracking the patients for an normal of more than five years, the team reported that while about 11 percent of patients without midwall fibrosis had died, nearly 27 percent of those with such scarring had died.
According to Gulati's team, assessments of midwall scarring based on MRI imaging might be valuable to doctors in pinpointing which patients with enlarged hearts are at highest gamble for death, disorderly heart rhythms and heart failure. Experts in the United States agreed that gauging the dimensions of scarring on the heart provides worthwhile information. "The severity of the dysfunction can be linked to the extent with which healthy heart muscle is replaced by nonfunctioning dent tissue," explained Dr Moshe Gunsburg, director of the cardiac arrhythmia accommodation and co-chief of the division of cardiology at Brookdale University Hospital and Medical Center, in New York City.
Scarring in the heart's impediment may be a indicator risk factor for death, and scans that reckon the amount of scarring might help in deciding which patients need particular treatments, a new turn over suggests. At issue is a kind of scarring, or fibrosis, known as midwall fibrosis. Reporting in the March 6 exit of the Journal of the American Medical Association, researchers found that patients with enlarged hearts who had more of this strain of damage were more than five times more likely to experience sudden cardiac extermination compared to patients without such scarring. "Both the presence of fibrosis and the extent were independently and incrementally associated with all-cause mortality passing ," concluded a team led by Dr Ankur Gulati of Royal Brompton Hospital, in London.
In the study, the researchers took high-tech MRI scans of the hearts of 472 patients with dilated cardiomyopathy, a material of weakened and enlarged goodness that is often linked to consideration failure. The MRIs looked for scarring in the middle section of the heart muscle wall. Tracking the patients for an normal of more than five years, the team reported that while about 11 percent of patients without midwall fibrosis had died, nearly 27 percent of those with such scarring had died.
According to Gulati's team, assessments of midwall scarring based on MRI imaging might be valuable to doctors in pinpointing which patients with enlarged hearts are at highest gamble for death, disorderly heart rhythms and heart failure. Experts in the United States agreed that gauging the dimensions of scarring on the heart provides worthwhile information. "The severity of the dysfunction can be linked to the extent with which healthy heart muscle is replaced by nonfunctioning dent tissue," explained Dr Moshe Gunsburg, director of the cardiac arrhythmia accommodation and co-chief of the division of cardiology at Brookdale University Hospital and Medical Center, in New York City.
Thursday, 21 November 2019
Another Type Of Congenital Heart Disease May Be Cured By The Device And The Surgery
Another Type Of Congenital Heart Disease May Be Cured By The Device And The Surgery.
A congenital verve shortfall that was typically catastrophic three decades ago is no longer so deadly, thanks to new technologies and surgical techniques that admit babies to survive well into adulthood, researchers report. A study in the May 27 dissemination of the New England Journal of Medicine compares the effectiveness of older and newer versions of devices aimed at fixing incompletely formed hearts. The writing-room finds both performing equally well over three years.
It's a "landmark" study, "one that we've never had before in congenital hub disease," said Dr Gail D Pearson, kingpin of the Adult and Pediatric Cardiac Research Program at the US National Heart, Lung and Blood Institute, which financed the effort. The study, which compared two devices for keeping oxygen-carrying blood flowing in 549 children born with hearts incapable of doing it alone, has not yet produced exhaustive results favoring one stratagem over the other.
But the probing is indeed just beginning. "Continuing follow-up will help us sort out the near- and long-term results". Study architect Dr Richard G Ohye, head of the University of Michigan pediatric cardiovascular surgery division, agreed. "Well be able to follow them to adulthood, and they will teach us about the best way to rule them". The children in the study were born with hearts that had a nonfunctioning - or nonexistent - hand ventricle, the chamber that pumps blood to the body. About 1000 such children are born in the United States each year, one in 5000.
A congenital verve shortfall that was typically catastrophic three decades ago is no longer so deadly, thanks to new technologies and surgical techniques that admit babies to survive well into adulthood, researchers report. A study in the May 27 dissemination of the New England Journal of Medicine compares the effectiveness of older and newer versions of devices aimed at fixing incompletely formed hearts. The writing-room finds both performing equally well over three years.
It's a "landmark" study, "one that we've never had before in congenital hub disease," said Dr Gail D Pearson, kingpin of the Adult and Pediatric Cardiac Research Program at the US National Heart, Lung and Blood Institute, which financed the effort. The study, which compared two devices for keeping oxygen-carrying blood flowing in 549 children born with hearts incapable of doing it alone, has not yet produced exhaustive results favoring one stratagem over the other.
But the probing is indeed just beginning. "Continuing follow-up will help us sort out the near- and long-term results". Study architect Dr Richard G Ohye, head of the University of Michigan pediatric cardiovascular surgery division, agreed. "Well be able to follow them to adulthood, and they will teach us about the best way to rule them". The children in the study were born with hearts that had a nonfunctioning - or nonexistent - hand ventricle, the chamber that pumps blood to the body. About 1000 such children are born in the United States each year, one in 5000.
Wednesday, 20 November 2019
Adult Smokers Quit Smoking Fast In The US
Adult Smokers Quit Smoking Fast In The US.
The Twin Cities of Minneapolis and St Paul aphorism a caustic decline in the number of grown-up smokers over the last three decades, perhaps mirroring trends elsewhere in the United States, experts say. The dip was due not only to more quitters, but fewer people choosing to smoke in the pre-eminent place, according to research presented Sunday at the annual meeting of the American Heart Association (AHA), in Chicago. But there was one worrying trend: Women were picking up the habit at a younger age.
One connoisseur said the findings reflected trends he's noticed in New York City. "I don't behold that many people who smoke these days. Over the last couple of decades the tremendous pre-eminence on the dangers of smoking has gradually permeated our society and while there are certainly people who continue to smoke and have been smoking for years and begin now, for a category of reasons I think that smoking is decreasing," said Dr Jeffrey S Borer, chairman of the sphere of medicine and of cardiovascular medicine at the State University of New York (SUNY) Downstate Medical Center. "If the Minnesota material is showing a decline, that's presumably a microcosm of what's happening elsewhere".
The findings come after US regulators on Thursday unveiled proposals to sum graphic images and more strident anti-smoking messages on cigarette packages to make an effort to shock people into staying away from cigarettes. The authors of the immature study, from the University of Minnesota, Minneapolis, canvassed residents of the Twin Cities on their smoking habits six extraordinary times, from 1980 to 2009. Each time, 3000 to 6000 rank and file participated.
About 72 percent of adults aged 25 to 74 reported ever having smoked a cigarette in 1980, but by 2009 that add had fallen to just over 44 percent among men. For women, the issue who had ever smoked fell from just under 55 percent in 1980 to 39,6 percent 30 years later.
The allotment of current male smokers was cut roughly in half, declining from just under 33 percent in 1980 to 15,5 percent in 2009. For women, the relinquish was even more striking, from about 33 percent in 1980 to just over 12 percent currently. Smokers are consuming fewer cigarettes per heyday now, as well, the boning up found. Overall, men cut down to 13,5 cigarettes a daytime in 2009 from 23,5 (a little more than a pack) in 1980 and there was a similar fad in women, the authors reported.
The Twin Cities of Minneapolis and St Paul aphorism a caustic decline in the number of grown-up smokers over the last three decades, perhaps mirroring trends elsewhere in the United States, experts say. The dip was due not only to more quitters, but fewer people choosing to smoke in the pre-eminent place, according to research presented Sunday at the annual meeting of the American Heart Association (AHA), in Chicago. But there was one worrying trend: Women were picking up the habit at a younger age.
One connoisseur said the findings reflected trends he's noticed in New York City. "I don't behold that many people who smoke these days. Over the last couple of decades the tremendous pre-eminence on the dangers of smoking has gradually permeated our society and while there are certainly people who continue to smoke and have been smoking for years and begin now, for a category of reasons I think that smoking is decreasing," said Dr Jeffrey S Borer, chairman of the sphere of medicine and of cardiovascular medicine at the State University of New York (SUNY) Downstate Medical Center. "If the Minnesota material is showing a decline, that's presumably a microcosm of what's happening elsewhere".
The findings come after US regulators on Thursday unveiled proposals to sum graphic images and more strident anti-smoking messages on cigarette packages to make an effort to shock people into staying away from cigarettes. The authors of the immature study, from the University of Minnesota, Minneapolis, canvassed residents of the Twin Cities on their smoking habits six extraordinary times, from 1980 to 2009. Each time, 3000 to 6000 rank and file participated.
About 72 percent of adults aged 25 to 74 reported ever having smoked a cigarette in 1980, but by 2009 that add had fallen to just over 44 percent among men. For women, the issue who had ever smoked fell from just under 55 percent in 1980 to 39,6 percent 30 years later.
The allotment of current male smokers was cut roughly in half, declining from just under 33 percent in 1980 to 15,5 percent in 2009. For women, the relinquish was even more striking, from about 33 percent in 1980 to just over 12 percent currently. Smokers are consuming fewer cigarettes per heyday now, as well, the boning up found. Overall, men cut down to 13,5 cigarettes a daytime in 2009 from 23,5 (a little more than a pack) in 1980 and there was a similar fad in women, the authors reported.
Subscribe to:
Posts (Atom)